Side effects across medicines
Medicines whose labels list weight gain
376 medicines have an FDA label that names weight gain in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of weight gain name methotrexate (11,971), pregabalin (11,621) and adalimumab (10,521), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list weight gain?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 152 of the 376 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of weight gain |
|---|---|---|
| Furosemide | precautions | 7,438 |
| Olanzapine | warnings and precautions (intramuscular label) | 6,833 |
| Diclofenac | precautions (oral label) | 5,366 |
| Clonazepam | precautions | 4,580 |
| Bisoprolol | precautions | 1,484 |
| Medroxyprogesterone | warnings and precautions (subcutaneous label) | 821 |
| Asenapine | warnings and precautions (transdermal label) | 564 |
| Ziprasidone | warnings and precautions (intramuscular label) | 279 |
| Isosorbide mononitrate | precautions | 215 |
| Clomipramine | precautions | 114 |
| Nabumetone | precautions | 103 |
| Etodolac | precautions | 97 |
| Carbidopa | precautions | none in the top 1,000 |
| Clomiphene | precautions | none in the top 1,000 |
| Diflunisal | precautions | none in the top 1,000 |
| Hydrocodone and ibuprofen | precautions | none in the top 1,000 |
| Isradipine | precautions | none in the top 1,000 |
| Ketorolac | precautions | none in the top 1,000 |
| Meclofenamate | precautions | none in the top 1,000 |
| Menotropins | warnings and precautions | none in the top 1,000 |
| Methyldopa | precautions | none in the top 1,000 |
| Rotigotine | warnings and precautions | none in the top 1,000 |
| Sulindac | precautions | none in the top 1,000 |
| Tiagabine | precautions | none in the top 1,000 |
| Tolmetin | precautions | none in the top 1,000 |
| Pregabalin | adverse reactions | 11,621 |
| Risperidone | adverse reactions | 9,189 |
| Quetiapine | adverse reactions | 8,382 |
| Aripiprazole | adverse reactions | 7,849 |
| Tocilizumab | adverse reactions | 7,429 |
| Gabapentin | adverse reactions | 7,083 |
| Rituximab | adverse reactions | 6,782 |
| Omeprazole | adverse reactions | 6,026 |
| Celecoxib | adverse reactions | 4,249 |
| Alprazolam | adverse reactions | 4,162 |
| Methylprednisolone | adverse reactions (intra-articular/ | 4,053 |
| Insulin glargine | adverse reactions | 3,859 |
| Levonorgestrel | adverse reactions (intrauterine label) | 3,854 |
| Venlafaxine | adverse reactions | 3,580 |
| Amlodipine | adverse reactions | 3,465 |
| Escitalopram | adverse reactions | 3,320 |
| Lamotrigine | adverse reactions | 3,191 |
| Bupropion | adverse reactions | 3,102 |
| Ramipril | adverse reactions | 3,094 |
| Citalopram | adverse reactions | 3,023 |
| Dexamethasone | adverse reactions | 2,471 |
| Fluticasone | adverse reactions (respiratory (inhalation) label) | 2,322 |
| Cortisone | adverse reactions | 2,319 |
| Insulin lispro | adverse reactions | 2,285 |
| Carvedilol | adverse reactions | 2,219 |
| Divalproex | adverse reactions | 2,168 |
| Prednisolone | adverse reactions | 2,040 |
| Mirtazapine | adverse reactions | 2,001 |
| Ruxolitinib | adverse reactions | 1,996 |
| Varenicline | adverse reactions | 1,976 |
| Etonogestrel | adverse reactions | 1,964 |
| Leuprolide | adverse reactions | 1,796 |
| Estradiol | adverse reactions | 1,795 |
| Clozapine | adverse reactions | 1,794 |
| Brexpiprazole | adverse reactions | 1,702 |
| Paliperidone | adverse reactions | 1,655 |
| Fluticasone and salmeterol | adverse reactions | 1,484 |
| Duloxetine | adverse reactions | 1,349 |
| Triamcinolone | adverse reactions (intra-articular/ | 1,336 |
| Pioglitazone | adverse reactions | 1,301 |
| Insulin aspart | adverse reactions | 1,271 |
| Baclofen | adverse reactions | 1,251 |
| Cyclobenzaprine | adverse reactions | 1,228 |
| Haloperidol | adverse reactions (intramuscular label) | 1,228 |
| Lithium | adverse reactions | 1,190 |
| Natalizumab | adverse reactions | 1,122 |
| Paroxetine | adverse reactions | 1,117 |
| Lurasidone | adverse reactions | 1,095 |
| Clonidine | adverse reactions | 1,067 |
| Estrogens conjugated | adverse reactions | 1,027 |
| Diltiazem | adverse reactions | 1,018 |
| Upadacitinib | adverse reactions | 1,009 |
| Insulin human | adverse reactions | 920 |
| Letrozole | adverse reactions | 920 |
| Relugolix | adverse reactions | 864 |
| Anastrozole | adverse reactions | 855 |
| Tacrolimus | adverse reactions | 841 |
| Aprepitant | adverse reactions (intravenous label) | 822 |
| Mometasone | adverse reactions (topical label) | 821 |
| Oxcarbazepine | adverse reactions | 768 |
| Desvenlafaxine | adverse reactions | 690 |
| Drospirenone and ethinyl estradiol | adverse reactions | 671 |
| Lisdexamfetamine | adverse reactions | 658 |
| Glimepiride | adverse reactions | 640 |
| Dexlansoprazole | adverse reactions | 599 |
| Valproic acid | adverse reactions | 598 |
| Vortioxetine | adverse reactions | 597 |
| Insulin degludec | adverse reactions | 568 |
| Glyburide | adverse reactions | 547 |
| Progesterone | adverse reactions | 536 |
| Deflazacort | adverse reactions | 531 |
| Pomalidomide | adverse reactions | 515 |
| Cariprazine | adverse reactions | 477 |
| Glatiramer | adverse reactions | 438 |
| Ethinyl estradiol and etonogestrel | adverse reactions | 418 |
| Methadone | adverse reactions | 416 |
| Lorlatinib | adverse reactions | 399 |
| Eszopiclone | adverse reactions | 372 |
| Zoledronic acid | adverse reactions | 370 |
| Carbidopa and levodopa | adverse reactions | 361 |
| Imatinib | adverse reactions | 354 |
| Testosterone | adverse reactions (transdermal label) | 353 |
| Amitriptyline | adverse reactions | 334 |
| Naltrexone | adverse reactions | 333 |
| Nilotinib | adverse reactions | 326 |
| Trazodone | adverse reactions | 319 |
| Indomethacin | adverse reactions | 315 |
| Exemestane | adverse reactions | 304 |
| Vilazodone | adverse reactions | 298 |
| Buspirone | adverse reactions | 292 |
| Doxepin | adverse reactions | 288 |
| Pramipexole | adverse reactions | 277 |
| Tretinoin | adverse reactions (oral label) | 255 |
| Vamorolone | adverse reactions | 254 |
| Raloxifene | adverse reactions | 242 |
| Prochlorperazine | adverse reactions | 233 |
| Valbenazine | adverse reactions | 222 |
| Aripiprazole lauroxil | adverse reactions | 215 |
| Cholestyramine | adverse reactions | 214 |
| Linagliptin | adverse reactions | 213 |
| Loxapine | adverse reactions | 209 |
| Alectinib | adverse reactions | 208 |
| Guanfacine | adverse reactions | 203 |
| Insulin glulisine | adverse reactions | 196 |
| Baricitinib | adverse reactions | 187 |
| Hydrochlorothiazide and lisinopril | adverse reactions | 178 |
| Norethindrone | adverse reactions | 178 |
| Bicalutamide | adverse reactions | 175 |
| Goserelin | adverse reactions | 173 |
| Thalidomide | adverse reactions | 173 |
| Doxorubicin | adverse reactions | 163 |
| Zonisamide | adverse reactions | 159 |
| Canakinumab | adverse reactions | 155 |
| Lubiprostone | adverse reactions | 154 |
| Oxaliplatin | adverse reactions | 154 |
| Nadolol | adverse reactions | 153 |
| Nortriptyline | adverse reactions | 153 |
| Ketoprofen | adverse reactions | 148 |
| Perampanel | adverse reactions | 147 |
| Betamethasone | adverse reactions (intra-articular/ | 136 |
| Tamoxifen | adverse reactions | 132 |
| Interferon beta 1b | adverse reactions | 131 |
| Terazosin | adverse reactions | 125 |
| Phenelzine | adverse reactions | 122 |
| Vigabatrin | adverse reactions | 122 |
| Methotrexate | patient leaflet | 11,971 |
| Adalimumab | patient leaflet | 10,521 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most weight gain reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Weight Increased”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch